Old Web
English
Sign In
Acemap
>
Paper
>
Patient-Reported outcomes from Phase 3 Baricitinib Ra-Begin Study: Latin American Subgroup Analysis
Patient-Reported outcomes from Phase 3 Baricitinib Ra-Begin Study: Latin American Subgroup Analysis
2017
M Papadimitropoulos
C Zerbini
C. Ramos-Remus
P Martinez-Osuna
Baojin Zhu
C. Gaich
Eg Garcia
Lf Golcalves
Keywords:
Baricitinib
Physical therapy
Latin Americans
Subgroup analysis
Medicine
Intensive care medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]